[go: up one dir, main page]

AU7512287A - Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof - Google Patents

Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof

Info

Publication number
AU7512287A
AU7512287A AU75122/87A AU7512287A AU7512287A AU 7512287 A AU7512287 A AU 7512287A AU 75122/87 A AU75122/87 A AU 75122/87A AU 7512287 A AU7512287 A AU 7512287A AU 7512287 A AU7512287 A AU 7512287A
Authority
AU
Australia
Prior art keywords
htlv
transcriptase
expression
iii
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75122/87A
Inventor
Stephen P. Goff
William A. Haseltine
Naoko Tanese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Dana Farber Cancer Institute Inc
Original Assignee
Columbia University in the City of New York
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York, Dana Farber Cancer Institute Inc filed Critical Columbia University in the City of New York
Publication of AU7512287A publication Critical patent/AU7512287A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU75122/87A 1986-05-20 1987-05-20 Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof Abandoned AU7512287A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86515686A 1986-05-20 1986-05-20
US865156 1997-05-29

Publications (1)

Publication Number Publication Date
AU7512287A true AU7512287A (en) 1987-12-22

Family

ID=25344859

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75122/87A Abandoned AU7512287A (en) 1986-05-20 1987-05-20 Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof

Country Status (3)

Country Link
JP (1) JPS63503356A (en)
AU (1) AU7512287A (en)
WO (1) WO1987007296A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2852431B2 (en) * 1988-12-07 1999-02-03 財団法人阪大微生物病研究会 Retroviral proteases, reverse transcriptases and endonucleases, and methods for producing these enzymes
HU209835B (en) * 1988-12-07 1994-11-28 Univ Osaka Res Found Method for producing of retrovirus protease, reverse transcriptase and integrase
WO1990010230A1 (en) * 1989-02-23 1990-09-07 University Of Ottawa Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
EP0514405B1 (en) * 1990-01-31 1995-01-04 The Upjohn Company Strain ral-4, useful for production of small proteins and peptides
US6080540A (en) * 1990-04-20 2000-06-27 Cold Spring Harbor Laboratory Cloning of mammalian genes in microbial organisms and methods for pharmacological screening
WO1992011028A1 (en) * 1990-12-19 1992-07-09 Epitope, Inc. Hiv reverse transcriptase vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2759053A1 (en) * 1977-12-30 1979-07-12 Uhlin METHOD FOR MANUFACTURING GENE PRODUCTS FROM PLASMID DNA

Also Published As

Publication number Publication date
WO1987007296A1 (en) 1987-12-03
JPS63503356A (en) 1988-12-08

Similar Documents

Publication Publication Date Title
AU609390B2 (en) Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs
AU617088B2 (en) Peptides involved in the pathogenesis of hiv infection
AU3063389A (en) Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
OA09499A (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) gp 120 and methods of use.
AU7715687A (en) Pharmaceutical composition of sulindac and tromethamine or sodium bicarbonate
AU8015587A (en) 4-amino-3-hydroxybutyronitrile and preparation of preparation of n-alkyl-3-pyrrolidinols
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
IL81858A0 (en) Acetamide derivatives,their preparation and pharmaceutical compositions containing them
AU2476388A (en) Therapeutic necleosides
GB9417249D0 (en) A novel salt
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
DK720588D0 (en) RELATIONSHIPS TO USE IN TREATMENT OR PREVENTION OF HUMAN IMMUNE INFECTIVE VIRUS (HIV) INFECTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
IL81568A0 (en) Plasmids which inhibit human t-cell lymphotropic virus type iii replication
AU3836489A (en) Treatment of immunodeficiency
AU5242490A (en) Sulfonyl derivatives of thieno-triazolo-diazepines, a preparation process of the same and therapeutic compositions containing them
AU8282187A (en) 5-hydroxyethyl derivatives of oxazolidinone-2, their preparation and their therapeutic uses
EP0311108A3 (en) Anti-hiv active 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
EP0308977A3 (en) Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus
IL90044A0 (en) Imidazolylmethyl-cycloalkane(b)indolones,their preparation and pharmaceutical compositions containing them
IT1225262B (en) METHOD FOR THE AWARENESS OF SMALL ANIMALS TO VIRUS INFECTION OF HUMAN IMMUNODEFICIENCY (HIV)
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AU6840487A (en) Plasmid and phage clones of human T-cell lymphotropic virus type III
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent